GENECHEM
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics Fund's objectives were to invest within the genomics industry but specifically in companies developing therapeutics for proliferative disorders including cancer, infectious diseases, inflammation and diabetes.
GENECHEM
Industry:
Genetics
Founded:
1997-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-09-03 | Osprey Pharmaceuticals USA | GeneChem investment in Series A - Osprey Pharmaceuticals USA | 11 M USD |
| 2007-11-14 | Ambit Biosciences | GeneChem investment in Series D - Ambit Biosciences | 49.3 M USD |
| 2007-01-30 | Osprey Pharmaceuticals USA | GeneChem investment in Venture Round - Osprey Pharmaceuticals USA | 9 M USD |
| 2007-01-18 | Cytochroma | GeneChem investment in Series C - Cytochroma | 21 M CAD |
| 2006-12-01 | Xanthus Pharmaceuticals | GeneChem investment in Series B - Xanthus Pharmaceuticals | 25 M USD |
| 2005-05-12 | Ambit Biosciences | GeneChem investment in Series C - Ambit Biosciences | 31 M USD |
| 2004-04-27 | NewBiotics | GeneChem investment in Series E - NewBiotics | 4.57 M USD |
| 2003-12-12 | Xanthus Pharmaceuticals | GeneChem investment in Series B - Xanthus Pharmaceuticals | 30.8 M USD |
| 2003-07-03 | LymphoSign | GeneChem investment in Series A - LymphoSign | 5.9 M USD |
| 2002-12-09 | Idun Pharmaceuticals | GeneChem investment in Series A - Idun Pharmaceuticals | 22.8 M USD |
More informations about "GeneChem"
GeneChem - About Us
1 Westmount Square, Suite 800 Montreal, Quebec H3Z 2P9 Canada. T 514-849-7696 F 514-849-5191 [email protected]See details»
Our Team - GeneChem
1 Westmount Square, Suite 800 Montreal, Quebec H3Z 2P9 Canada. T 514-849-7696 F 514-849-5191 [email protected]See details»
GeneChem - Crunchbase Investor Profile & Investments
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics …See details»
GeneChem - Venbridge
GeneChem is a manager of focused biotechnology venture capital funds. We have over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem …See details»
GeneChem Investor Profile: Portfolio & Exits - PitchBook
GeneChem General Information Company Description. Founded in 1997, GeneChem is a venture capital firm based in Montreal, Canada. The firm seeks to invest in United States, Canada, and …See details»
GeneChem - Crunchbase Company Profile & Funding
GeneChem Inc. is specialized in the development of health-related substances such as functional oligosaccharides, new bio-medicines, and gene therapy products, on the basis of the *omics technologies including nucleic acid …See details»
Genechem - VentureRadar
Founded in 2002, now with over 500 employees, Genechem works closely with Research Oncologists to translate clinical research into therapeutics addressing high clinical unmet …See details»
GeneChem - Investments, Portfolio & Company Exits - Crunchbase
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem. Search Crunchbase. ... Which industries has this …See details»
GeneChem - Genechem Technologies Venture Fund - About Us
GeneChem Technologies Venture Fund L.P. was launched in early 1997 to take advantage of the increasing opportunities afforded by the emerging genomics sector. With committed capital of …See details»
Shanghai Genechem Co., Ltd. (Genechem) Announces Global …
Apr 6, 2021 Genechem is a leading innovation research company focused on target discovery/validation, development of antibody and cell therapy products against novel targets, …See details»
Shanghai Genechem Co., Ltd. (Genechem) Announces Global …
SHANGHAI, April 6, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel …See details»
GeneChem - Funding, Financials, Valuation & Investors - Crunchbase
GeneChem 's most notable exits include Cyclacel Pharmaceuticals and BioVex. Which industries has this organization had the most exits in? Show . Cyclacel Pharmaceuticals Cyclacel …See details»
Debut Biotech and GeneChem to Develop Rare Ingredients for …
Jul 7, 2022 Human milk oligosaccharides (HMOs) to address performance nutritional gaps from infant formula to nutritional consumer goods. SAN DIEGO, July 7, 2022 /PRNewswire-PRWeb/ …See details»
GeneChem - Genechem Therapeutics Venture Fund - About Us
1 Westmount Square, Suite 800 Montreal, Quebec H3Z 2P9 Canada. T 514-849-7696 F 514-849-5191 [email protected]See details»
GeneChem builds a commercial-scale factory to meet
Feb 28, 2022 GeneChem is a leading player in the glycosylation industry, particularly specializing in sialylation. Its One-Pot Enzyme Reaction System and sialyllactose production …See details»
GeneChem - Genechem Technologies Venture Fund - Portfolio
1 Westmount Square, Suite 800 Montreal, Quebec H3Z 2P9 Canada. T 514-849-7696 F 514-849-5191 [email protected]See details»
GeneChem - Contacts, Employees, Board Members, Advisors
GeneChem has 8 current employee profiles, including Administrative Assistant Fabienne Perreau. Fabienne Perreau Administrative Assistant. Martial Lacroix General Partner. Inès Holzbaur …See details»
Bringing biomedical discoveries from lab to hospital - Nature
Credit: Genechem. Organized by Shanghai Genechem, a biotech company committed to promoting innovations in translational medicine, this was the second annual forum, and an …See details»
Genechem (China) - Crunchbase Company Profile & Funding
Genechem (China) closed its last funding round on Apr 3, 2020 from a Series C round. Who are Genechem (China) 's competitors? Alternatives and possible competitors to Genechem …See details»